The International Journal of Artificial Organs · Nov 19, 2026

Prognostic value of C-reactive protein/albumin ratio in predicting mortality in hemodialysis patients

By Yilmaz Aydin E, Altuntaş A, Aydin Ü et al.

Objective: Systemic inflammation and malnutrition are critical determinants of mortality in hemodialysis patients. The C-reactive protein/albumin ratio (CAR) integrates these two pathways. This study aimed to assess the prognostic value of CAR for all-cause mortality in maintenance hemodialysis patients and compare it with other inflammatory biomarkers. Methods: This multicenter retrospective study included 204 hemodialysis patients followed between January 2022 and January 2024. Patients were stratified into survivor ( n = 161) and non-survivor ( n = 43) groups. Demographic data and inflammatory biomarkers, including CAR, neutrophil/lymphocyte ratio (NLR), and systemic immune-inflammation index (SII), were analyzed. Multivariate logistic regression was used to identify independent predictors of mortality. Results: Non-survivors exhibited significantly higher median CAR levels (3.86 vs 1.72, p < 0.001) and lower Kt/V values compared to survivors. In ROC analysis, 6-month average Kt/V (AUC = 0.764) and RAR (AUC = 0.751) showed high discriminatory power, followed by CAR (AUC = 0.715). However, in multivariate regression, high CAR (>2.59) remained a robust independent predictor of mortality (odds ratio: 3.61, p = 0.002), alongside age and Kt/V, whereas RDW lost its significance. Conclusions: CAR may serve as a simple, cost-effective, and independent prognostic marker for all-cause mortality in hemodialysis patients. While dialysis adequacy (Kt/V) remains the dominant predictor, integrating CAR into routine monitoring has the potential to enhance risk stratification by capturing the malnutrition-inflammation burden, pending validation in future prospective cohorts.

doi.org/10.1177/03913988261446077Open accessPubMed 43055223Biomarkers

AgingResearch.News